4-methylpyrazole formulations

Details for Australian Patent Application No. 2010328375 (hide)

Owner Raptor Pharmaceuticals Inc.

Inventors Daley, Thomas E.; Powell, Kathy; Jarzebinski, Olga

Agent Henry Hughes Ltd

Pub. Number AU-A-2010328375

PCT Pub. Number WO2011/071805

Priority 61/267,389 07.12.09 US

Filing date 6 December 2010

Wipo publication date 16 June 2011

International Classifications

A61K 31/415 (2006.01) - 1,2-Diazoles

A61P 25/32 (2006.01) Drugs for disorders of the nervous system

Event Publications

5 April 2012 PCT application entered the National Phase

  PCT publication WO2011/071805 Priority application(s): WO2011/071805

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010328391-Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl) - 1-{6-[4-(4-ethyl-piperazin-1-yl)-phenyla mino] -pyrimidin-4-yl}-1-methyl-urea and salts thereof.

2010328373-Hydroprocessing of high nitrogen feed using bulk catalyst